anti β3 tubulin (Cell Signaling Technology Inc)
Structured Review
Anti β3 Tubulin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+tubulin/pmc12992974-282-53-55
Average 86 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Progesterone-driven stabilization of hybrid E/M states in amniotic epithelial cells enhances regeneration and immune modulatory capacities Article Snippet: Article Title: Identification of a lineage-agnostic splicing signature caused by PRMT5 inhibition Article Snippet: Anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH), Anti-Tubulin, Anti-SDMA, Anti-PRMT5, and Article Title: Targeting PI3K γ anchoring enhances CFTR membrane localization and modulator efficacy via PKD1 Article Snippet: The Saline:Article Title: The REDD1-NF-κB-miRNAs-eNOS/SIRT1 axis mediates obesity-induced endothelial cell senescence and hypertension. Article Snippet: The resulting immunoprecipitates and cell lysates (30−40 μg protein) were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride membranes (#GE10600023; Cytiva, Marlborough, MA, USA). .. The membranes were blocked with 5% bovine serum albumin (BSA, #BSAS0.1; Bovogen Biologicals Pty Ltd., Australia) in Tris-buffered saline (50 mM TrisCl pH 7.5, 150 mM NaCl) containing 0.05% Tween-20 and analyzed using immunoblotting with the respective primary antibodies: ant-eNOS (1:1000, #PA1-037, RRID: AB_325774; Invitrogen), antiDICER (1:1000, #5362, RRID: AB_2093073; Cell Signaling Technology), anti-IKKβ (1:1000, #2684, RRID: AB_2122298; Cell Signaling Technology), anti-REDD1 (1:1000, #10638-1-AP, RRID: AB_2245711; Proteintech), anti-p65 (1:1000, #8242T, RRID: AB_10859369; Cell Signaling Technology), anti-p53 (1:1000, #2524, RRID: AB_331743; Cell Signaling Technology), anti-acetyl-p53 (1:1000, #2570, RRID: AB_823591; Cell Signaling Technology), anti-p21 (1:1000, #SC-6246, RRID: AB_823591; Santa Cruz, Santa Cruz, CA, USA), anti-p16 (1:1000, #SC-1661, RRID: AB_628067; Santa Cruz), anti-SIRT1 (1:1000, #8469S, RRID: AB_10999470; Cell Signaling Technology), anti-ICAM-1 (1:1000, #MA5407, AR TI CL E IN P RE SS ARTICLE IN PRESS RRID: AB_223596; Invitrogen), anti-VCAM-1 (1:1000, #MA5-31965, RRID: AB_2809259; Invitrogen), anti-Raptor (1:1000, #2280, RRID: AB_561245; Cell Signaling Technology), anti-phospho-S6K (Thr, 1:1000, #9234, RRID: AB_2269803; Cell Signaling Technology), anti-S6K (1:1000, #34475, RRID: AB_2943679; Cell Signaling Technology), anti-phospho-4E-BP1 (Thr37/46, 1:1000, #9459, RRID: AB_330985; Cell Signaling Technology), anti-4E-BP1 (1:1000, #9452, RRID: AB_331692; Cell Signaling Technology), anti- -actin (1:5000, #A5441, RRID: AB_476744; Sigma-Aldrich), anti-TXNIP (1:1000, #14715, RRID: AB_2714178, Cell Signaling Technology), or Article Title: The REDD1-NF-κB-miRNAs-eNOS/SIRT1 axis mediates obesity-induced endothelial cell senescence and hypertension. Article Snippet: The resulting immunoprecipitates and cell lysates (30−40 μg protein) were separated by sodium dodecyl sulfate- polyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride membranes (#GE10600023; Cytiva, Marlborough, MA, USA). .. The membranes were blocked with 5% bovine serum albumin (BSA, #BSAS0.1; Bovogen Biologicals Pty Ltd., Australia) in Tris-buffered saline (50 mM Tris- Cl pH 7.5, 150 mM NaCl) containing 0.05% Tween-20 and analyzed using immunoblotting with the respective primary antibodies: ant-eNOS (1:1000, #PA1-037, RRID: AB_325774; Invitrogen), anti- DICER (1:1000, #5362, RRID: AB_2093073; Cell Signaling Technology), anti-IKKβ (1:1000, #2684, RRID: AB_2122298; Cell Signaling Technology), anti-REDD1 (1:1000, #10638-1-AP, RRID: AB_2245711; Proteintech), anti-p65 (1:1000, #8242T, RRID: AB_10859369; Cell Signaling Technology), anti-p53 (1:1000, #2524, RRID: AB_331743; Cell Signaling Technology), anti-acetyl-p53 (1:1000, #2570, RRID: AB_823591; Cell Signaling Technology), anti-p21 (1:1000, #SC-6246, RRID: AB_823591; Santa Cruz, Santa Cruz, CA, USA), anti-p16 (1:1000, #SC-1661, RRID: AB_628067; Santa Cruz), anti-SIRT1 (1:1000, #8469S, RRID: AB_10999470; Cell Signaling Technology), anti-ICAM-1 (1:1000, #MA5407, AR TI CL E IN P RE SS RRID: AB_223596; Invitrogen), anti-VCAM-1 (1:1000, #MA5-31965, RRID: AB_2809259; Invitrogen), anti-Raptor (1:1000, #2280, RRID: AB_561245; Cell Signaling Technology), anti-phospho-S6K (Thr389, 1:1000, #9234, RRID: AB_2269803; Cell Signaling Technology), anti-S6K (1:1000, #34475, RRID: AB_2943679; Cell Signaling Technology), anti-phospho-4E-BP1 (Thr37/46, 1:1000, #9459, RRID: AB_330985; Cell Signaling Technology), anti-4E-BP1 (1:1000, #9452, RRID: AB_331692; Cell Signaling Technology), anti--actin (1:5000, #A5441, RRID: AB_476744; Sigma-Aldrich), anti-TXNIP (1:1000, #14715, RRID: AB_2714178, Cell Signaling Technology), or Western Blot:Article Title: The REDD1-NF-κB-miRNAs-eNOS/SIRT1 axis mediates obesity-induced endothelial cell senescence and hypertension. Article Snippet: The resulting immunoprecipitates and cell lysates (30−40 μg protein) were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride membranes (#GE10600023; Cytiva, Marlborough, MA, USA). .. The membranes were blocked with 5% bovine serum albumin (BSA, #BSAS0.1; Bovogen Biologicals Pty Ltd., Australia) in Tris-buffered saline (50 mM TrisCl pH 7.5, 150 mM NaCl) containing 0.05% Tween-20 and analyzed using immunoblotting with the respective primary antibodies: ant-eNOS (1:1000, #PA1-037, RRID: AB_325774; Invitrogen), antiDICER (1:1000, #5362, RRID: AB_2093073; Cell Signaling Technology), anti-IKKβ (1:1000, #2684, RRID: AB_2122298; Cell Signaling Technology), anti-REDD1 (1:1000, #10638-1-AP, RRID: AB_2245711; Proteintech), anti-p65 (1:1000, #8242T, RRID: AB_10859369; Cell Signaling Technology), anti-p53 (1:1000, #2524, RRID: AB_331743; Cell Signaling Technology), anti-acetyl-p53 (1:1000, #2570, RRID: AB_823591; Cell Signaling Technology), anti-p21 (1:1000, #SC-6246, RRID: AB_823591; Santa Cruz, Santa Cruz, CA, USA), anti-p16 (1:1000, #SC-1661, RRID: AB_628067; Santa Cruz), anti-SIRT1 (1:1000, #8469S, RRID: AB_10999470; Cell Signaling Technology), anti-ICAM-1 (1:1000, #MA5407, AR TI CL E IN P RE SS ARTICLE IN PRESS RRID: AB_223596; Invitrogen), anti-VCAM-1 (1:1000, #MA5-31965, RRID: AB_2809259; Invitrogen), anti-Raptor (1:1000, #2280, RRID: AB_561245; Cell Signaling Technology), anti-phospho-S6K (Thr, 1:1000, #9234, RRID: AB_2269803; Cell Signaling Technology), anti-S6K (1:1000, #34475, RRID: AB_2943679; Cell Signaling Technology), anti-phospho-4E-BP1 (Thr37/46, 1:1000, #9459, RRID: AB_330985; Cell Signaling Technology), anti-4E-BP1 (1:1000, #9452, RRID: AB_331692; Cell Signaling Technology), anti- -actin (1:5000, #A5441, RRID: AB_476744; Sigma-Aldrich), anti-TXNIP (1:1000, #14715, RRID: AB_2714178, Cell Signaling Technology), or Article Title: The REDD1-NF-κB-miRNAs-eNOS/SIRT1 axis mediates obesity-induced endothelial cell senescence and hypertension. Article Snippet: The resulting immunoprecipitates and cell lysates (30−40 μg protein) were separated by sodium dodecyl sulfate- polyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride membranes (#GE10600023; Cytiva, Marlborough, MA, USA). .. The membranes were blocked with 5% bovine serum albumin (BSA, #BSAS0.1; Bovogen Biologicals Pty Ltd., Australia) in Tris-buffered saline (50 mM Tris- Cl pH 7.5, 150 mM NaCl) containing 0.05% Tween-20 and analyzed using immunoblotting with the respective primary antibodies: ant-eNOS (1:1000, #PA1-037, RRID: AB_325774; Invitrogen), anti- DICER (1:1000, #5362, RRID: AB_2093073; Cell Signaling Technology), anti-IKKβ (1:1000, #2684, RRID: AB_2122298; Cell Signaling Technology), anti-REDD1 (1:1000, #10638-1-AP, RRID: AB_2245711; Proteintech), anti-p65 (1:1000, #8242T, RRID: AB_10859369; Cell Signaling Technology), anti-p53 (1:1000, #2524, RRID: AB_331743; Cell Signaling Technology), anti-acetyl-p53 (1:1000, #2570, RRID: AB_823591; Cell Signaling Technology), anti-p21 (1:1000, #SC-6246, RRID: AB_823591; Santa Cruz, Santa Cruz, CA, USA), anti-p16 (1:1000, #SC-1661, RRID: AB_628067; Santa Cruz), anti-SIRT1 (1:1000, #8469S, RRID: AB_10999470; Cell Signaling Technology), anti-ICAM-1 (1:1000, #MA5407, AR TI CL E IN P RE SS RRID: AB_223596; Invitrogen), anti-VCAM-1 (1:1000, #MA5-31965, RRID: AB_2809259; Invitrogen), anti-Raptor (1:1000, #2280, RRID: AB_561245; Cell Signaling Technology), anti-phospho-S6K (Thr389, 1:1000, #9234, RRID: AB_2269803; Cell Signaling Technology), anti-S6K (1:1000, #34475, RRID: AB_2943679; Cell Signaling Technology), anti-phospho-4E-BP1 (Thr37/46, 1:1000, #9459, RRID: AB_330985; Cell Signaling Technology), anti-4E-BP1 (1:1000, #9452, RRID: AB_331692; Cell Signaling Technology), anti--actin (1:5000, #A5441, RRID: AB_476744; Sigma-Aldrich), anti-TXNIP (1:1000, #14715, RRID: AB_2714178, Cell Signaling Technology), or Article Title: Inducible CD147 up-regulation boosts extended SARS-CoV-2 infection triggering severe COVID-19 independent of ACE2 Article Snippet: Subsequently, the membranes were blocked with NcmBlot blocking buffer ( P30500 , NCM Biotech) and incubated with the primary antibodies at 4 °C overnight. .. The images were obtained after the incubation of secondary antibodies at room temperature for 1 h. The antibodies used in western blot were listed as follows: Article Title: Granularity screening identifies candidate genes involved in vaccinia virus induced LC3 lipidation Article Snippet: Torin1 (MERCK Millipore) was used at 250 nM, 3-Methyladenine (3-MA) (Sigma Aldrich) was used at 5 mM. .. The following antibodies were used: Anti-LC3b (CST #3868S) used in IF at 1:200 and in WB at 1:1000; Incubation:Article Title: Inducible CD147 up-regulation boosts extended SARS-CoV-2 infection triggering severe COVID-19 independent of ACE2 Article Snippet: Subsequently, the membranes were blocked with NcmBlot blocking buffer ( P30500 , NCM Biotech) and incubated with the primary antibodies at 4 °C overnight. .. The images were obtained after the incubation of secondary antibodies at room temperature for 1 h. The antibodies used in western blot were listed as follows: |

